未知生产厂商
BI-K0376 is investigated for use/treatment in acne. BI-K0376 is a solid. It is under investigation by Pfizer and has gone through phase I of the clinical trails.
BI-K0376 is investigated for use/treatment in acne. BI-K0376 is a solid. It is under investigation by Pfizer and has gone through phase I of the clinical trails.
BI-K0376 has a unique mode of action that makes it extremely selective against the bacteria responsible for acne, Propionibacterium acnes, including those that have become resistant to other antibiotic treatments, whilst sparing normal skin bacterial flora.
Investigated for use/treatment in acne.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
